Darren Pangle, a Katy teacher known as the "miracle man," survived a severe illness against medical expectations thanks to ...

Dr. Loyalka calls his recovery miraculous. “He’s amazing. Within three months, he came to my office, and I remember — he was ...

InflaRx N.V. (Nasdaq: IFRX), a biopharmaceutical company pioneering anti-inflammatory therapeutics targeting the complement ...

Stellar Market Research reported that the Oxygenator Market is growing at a CAGR of 5.9 % over the period from 2025 to 2032. The Growing Geriatric Population is an important trend driving the growth ...

Mumbai: When 56-year-old businessman Nilesh Bhatt began feeling uneasy while visiting a Charni Road temple, he blamed it on the heat. He drank two bot.

Remdesivir was associated with a significant survival benefit and reduced risk for rehospitalization among inpatients with COVID-19 infection.

InflaRx ends its Phase 3 trial of vilobelimab in pyoderma gangrenosum and shifts focus to INF904 amid efforts to extend its ...

Inspira™ Technologies OXY B.H.N. Ltd. (NASDAQ: IINN) (“Inspira” or the “Company”), a pioneering company in advanced respiratory support and diagnostic systems, today announced an evolution in its ...

The Company’s expansion efforts come amid an increase in the global focus on scalable respiratory solutions, which may position the Company as a strtegic platform for public health initiatives and ...

After a poor showing of its COVID med vilobelimab in a rare skin disorder trial, German drugmaker InflaRx is going back to ...

CytoSorbents Corporation (NASDAQ: CTSO), a leader in the treatment of life-threatening conditions in the intensive care unit and cardiac surgery using blood purification, today announced that ...